HUBEKO Trademark

Trademark Overview

On Thursday, March 7, 2019, a trademark application was filed for HUBEKO with the United States Patent and Trademark Office. The USPTO has given the HUBEKO trademark a serial number of 79255635. The federal status of this trademark filing is REGISTERED as of Tuesday, February 11, 2020. This trademark is owned by Glaxo Group Limited. The HUBEKO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
hubeko

General Information

Serial Number79255635
Word MarkHUBEKO
Filing DateThursday, March 7, 2019
Status700 - REGISTERED
Status DateTuesday, February 11, 2020
Registration Number5980266
Registration DateTuesday, February 11, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type77 - NOT AVAILABLE
AddressGB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type77 - NOT AVAILABLE
AddressGB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type77 - NOT AVAILABLE
AddressGB

Trademark Events

Event DateEvent Description
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, August 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 27, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 27, 2020FINAL DISPOSITION PROCESSED
Monday, May 11, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 11, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 22, 2019EXAMINER'S AMENDMENT ENTERED
Monday, October 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 21, 2019EXAMINERS AMENDMENT E-MAILED
Monday, October 21, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, October 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 6, 2019NON-FINAL ACTION E-MAILED
Friday, September 6, 2019NON-FINAL ACTION WRITTEN
Monday, August 19, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 6, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, July 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 18, 2019ASSIGNED TO LIE
Friday, July 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 17, 2019REFUSAL PROCESSED BY IB
Tuesday, April 30, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 30, 2019REFUSAL PROCESSED BY MPU
Tuesday, April 9, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 9, 2019APPLICATION FILING RECEIPT MAILED
Monday, April 8, 2019NON-FINAL ACTION WRITTEN
Wednesday, April 3, 2019ASSIGNED TO EXAMINER
Wednesday, April 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 28, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

hubeko pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological